As of , Camlin Fine Sciences Ltd (Chemicals - Others) has a deep value score of 9/100 (rated Very Weak).
Based on Q3 FY26 earnings • Updated Apr 18, 2026
What: Tariff Reduction: 25% (from 50%)
Impact: $2-2.5 per kg realization
“But with the recent reduction of tariff to 25%, we can have a benefit of that on the 400 metric tons stock which we have.”
What: Vanillin Volume: 4,000 tons
Impact: Cost reduction to $8/kg
“At that utilization, our costs are $9.5-10. At full capacity, it will come to $8.”
What: Anti-dumping duty: 131% in EU
“Europe, the anti-dumping duty on Chinese material is 131%, whereas in the US, it's effectively with the tariffs at about 265%.”
What: Blends business growth of 13%
“As far as Blends is concerned... we have grown by around 11% the corresponding quarter and almost 13% this quarter.”
What: $12.5 → $14-14.5
“Now, if the duty becomes 25%... we will be selling at around $14-$14.5, pay the duty at 25% which will match the local price of $18.”
Earnings deceleration risks from management commentary
Trigger: A massive fire occurred at a machine being commissioned, destroying inventory and equipment.
Impact: PAT impact: ₹33 Cr book value loss
Management view: Using local tollers and sourcing from other geographies to maintain customer service; insurance survey pending.
Monitor: litigation
Trigger: Realizations depend on the official signing of trade deals to lower tariffs from 25% to 18%.
Management view: Delaying sales of 400 tons of stock to capture higher realizations post-tariff reduction.
Monitor: regulatory
Trigger: Intense competition in India and falling global prices for core antioxidant ingredients.
Management view: Focusing on the Blends business as the primary growth driver.
Monitor: commodity
Key quotes from recent conference calls
“This is regarding the guidance that was there of around Rs. 2,000-Rs. 2,100 crores kind of sales. [Previous Revenue guidance]”
“And do you feel you are confident of reiterating your guidance for about 2,500 tons-3,000 tons this year for Vanillin [Previous Vanillin Volume guidance]”
“The French company, Vinpai Limited Company, which contributed almost near to Rs. 13 crores in this quarter and that has also helped to grow the business. [Initiative: Vinpai Integration]”
“Got it. So, our run rate after this goes down, the China and the Europe, the EBITDA will improve by Rs. 9 crores per quarter. [Initiative: Europe Liquidation]”
Headline numbers from the latest earnings call
Revenue
₹572 Cr
Why: Revenue was flat sequentially but grew year-on-year due to higher Vanillin sales volumes despite tepid performance in the Straights business.
Management described the quarter as tepid despite the year-on-year growth.
Other Highlights
• Vanillin sales reached ₹55 Cr with a realization of $12.5 per kg.
• Blends business grew 13% this quarter, reaching ₹271 Cr.
• Brazil fire incident resulted in a total book value loss of ₹33 Cr.
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Vanillin Realization per kg
$12.5
Why: Realization remained flat due to the 50% tariff impact in the US market.
Vanillin Sales Volume
490 tons
Why: Volumes were controlled to wait for better realizations following tariff reductions.
Blends Business Revenue
₹271 Cr
Why: Growth driven by core business strength and the Vinpai acquisition.
Straights Business Revenue
₹80 Cr
Why: Impacted by falling prices and intense local competition in India.
Diphenol Plant Utilization
50-55%
Why: Operating at partial capacity while waiting for demand and realization recovery.
Vanillin Channel Inventory
550 tons
Why: Inventory held in internal channels and with financing distributors.
Vinpai Monthly Revenue Run-rate
₹12.5-13 Cr
Why: Current performance of the newly acquired French subsidiary.
Annual Maintenance CAPEX
₹40-50 Cr
Why: Standard requirement for maintaining large chemical facilities.
Forward-looking targets from management for FY27-FY28
OPM Guidance
12–14%
Capex Plan
₹50 Cr
₹2,200 Cr for FY27; ₹2,400 Cr for FY28
REAFFIRMED
₹40-50 Cr
Maintenance CAPEX
REAFFIRMED
Guidance Changes
Vanillin Realization: $12.5 → $14-14.5
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +6% | +6% | Decelerating |
| PAT (Net Profit) | -429% | -50% | Inflection Down |
| OPM | 5.0% | -800 bps | Volatile |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Camlin Fine Sciences Ltd has a deep value score of 9/100 (rated Very Weak). This score is calculated from three components
Camlin Fine Sciences Ltd's quarterly profit (PAT) growth trajectory
Camlin Fine Sciences Ltd is underperforming the market despite improving earnings — this is the core deep value thesis
Camlin Fine Sciences Ltd's earnings momentum is Monitoring.
Camlin Fine Sciences Ltd's valuation metrics
Camlin Fine Sciences Ltd's revenue and margin trends
Camlin Fine Sciences Ltd's trailing twelve month (TTM) performance
Camlin Fine Sciences Ltd key facts
Camlin Fine Sciences Ltd shows limited deep value signals currently — score is 9/100 (Very Weak). Monitor for improvement.
Deep value investing studies stocks that are underperforming the market despite showing improving fundamentals. The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap. It requires patience — recovery can take several quarters.
The deep value score (0-100) combines three factors:
- Earnings (0-40 pts): PAT growth across last 3 quarters, acceleration, and consecutive growth - Underperformance (0-35 pts): How much the stock trails Nifty 500 over 1Y, 6M, 3M (deeper underperformance = higher score) - Quality (0-25 pts): Revenue growth, margin trends, and valuation metrics (PEG, P/B)
Higher score indicates a stronger contrarian research signal.
Camlin Fine Sciences Ltd has 5 key growth catalysts identified from recent earnings analysis
Camlin Fine Sciences Ltd has 3 key risks worth monitoring
In Q3 FY26, Camlin Fine Sciences Ltd's management highlighted
The above FAQs are generated from publicly available earnings data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
